Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase 3 Study of ASP7374 - Open-label Study of Intramuscular ASP7374 in Adults ≥61 Years of Age

Next Previous
Trial Profile

Phase 3 Study of ASP7374 - Open-label Study of Intramuscular ASP7374 in Adults ≥61 Years of Age

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 24 Aug 2020

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Most Recent Events

  • 10 Jan 2017 According to an Astellas Pharma media release, the company will withdraw the application for marketing approval of ASP7374 which the company has filled in Japan as the company has terminated the development agreement with UMN Pharma.
  • 15 Jan 2014 Results from this trial were reported by Astellas Pharma and UMN Pharma, according to an UMN Pharma media release.
  • 01 Nov 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top